Inovio Pharmaceuticals Inc (INO)

[MountainMom]

Why INO has a $29 Price Target...

This is it in a nutshell folks. Ebola will not go away in West Africa without mass vaccination. As it grows it is likely to mutate which means the vaccine must be DNA smart or it will be worthless when it does mutate. Enter Innovio Pharmaceuticals and their SynCon, Smart DNA Platform which can be formulated to change with mutations. No one else has this. And most importantly according to CEO KIM they can make fifty thousand doses a week...critical.

"The higher the case count in West Africa goes, the more chances for further mutations, and therefore the greater possibility that the virus might adapt somehow to become more transmissible-perhaps by becoming less pathogenic, sickening or killing its victims more slowly and thereby leaving them more time to infect others."

We may see a new 52-week high this week.

http://news.nationalgeographic.com/news/2014/10/141015-ebola-virus-outbreak-pandemic-zoonotic-contagion/

http://www.smarteranalyst.com/2014/09/25/piper-jaffray-reiterates-buy-inovio-stock-rising-noise-ebola/